<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0">
  <channel>
    <title>Featured Headlines Feed for RIGL</title>
    <link />
    <description>Headlines for Rigel Pharmaceuticals, Inc.</description>
    <docs>http://www.rssboard.org/rss-specification</docs>
    <generator>Argotic Syndication Framework 2008.0.2.0, http://www.codeplex.com/Argotic</generator>
    <item>
      <title>3 Winners and 2 Losers From Rigel's Failure</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/06/15/can-rigel-wiggle-out-of-this-jam/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Sat, 15 Jun 2013 17:26:51 GMT</pubDate>
    </item>
    <item>
      <title>Commit To Purchase Rigel Pharmaceuticals At $2.50, Earn 11.3% Annualized</title>
      <link>http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11947484/1/commit-to-purchase-rigel-pharmaceuticals-at-250-earn-113-annualized.html.aspx?puc=aol&amp;cm_ven=aol&amp;source=itxwebtxt0000015</link>
      <author>TheStreet</author>
      <pubDate>Tue, 11 Jun 2013 14:19:00 GMT</pubDate>
    </item>
    <item>
      <title>This Week in Biotech</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/06/08/this-week-in-biotech-30/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Sat, 08 Jun 2013 12:10:00 GMT</pubDate>
    </item>
    <item>
      <title>3 Horrendous Health-Care Stocks This Week</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/06/08/3-horrendous-health-care-stocks-this-week-30/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Sat, 08 Jun 2013 09:15:00 GMT</pubDate>
    </item>
    <item>
      <title>AstraZeneca to Return Fostamatinib Rights - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/100913/astrazeneca-to-return-fostamatinib-rights.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Wed, 05 Jun 2013 22:15:01 GMT</pubDate>
    </item>
    <item>
      <title>UPDATE: Jefferies Lowers PT on Rigel Pharmaceuticals Following Return of Fostamatinib Rights</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/analyst-ratings/analyst-color/13/06/3650664/update-jefferies-lowers-pt-on-rigel-pharmaceuticals-foll.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Wed, 05 Jun 2013 11:42:42 GMT</pubDate>
    </item>
    <item>
      <title>Afternoon Market Losers</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/06/3647357/afternoon-market-losers.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Tue, 04 Jun 2013 14:44:10 GMT</pubDate>
    </item>
    <item>
      <title>Why Rigel Pharmaceuticals Shares Were Shellacked</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/06/04/why-rigel-pharmaceuticals-shares-were-shellacked/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Tue, 04 Jun 2013 13:25:00 GMT</pubDate>
    </item>
    <item>
      <title>UPDATE: Oppenheimer Downgrades Rigel Pharmaceuticals on Disappointing Ph.III OKSIRA-2/3 Studies</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/analyst-ratings/analyst-color/13/06/3647189/update-oppenheimer-downgrades-rigel-pharmaceuticals-on-d.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Tue, 04 Jun 2013 13:19:42 GMT</pubDate>
    </item>
    <item>
      <title>AstraZeneca Writes Off $140 Million Following Product Trial</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/06/04/astrazeneca-writes-off-140-million-following-produ/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Tue, 04 Jun 2013 10:55:00 GMT</pubDate>
    </item>
    <item>
      <title>Stock Downgrades: Railing Against Canadian Pacific</title>
      <link>http://www.fool.com/news/xt/minyanville/www.minyanville.com/trading-and-investing/stocks/articles/stock-downgrades253a-railing-against-canadian-pacific/6/4/2013/id/50157.aspx?source=itxwebtxt0000015</link>
      <author>Minyanville</author>
      <pubDate>Tue, 04 Jun 2013 09:22:00 GMT</pubDate>
    </item>
    <item>
      <title>U.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH</title>
      <link>http://www.fool.com/news/xt/smartmoney/www.smartmoney.com/news/on/.aspx?story=on-20130604-000189&amp;cid=1244&amp;source=itxwebtxt0000015</link>
      <author>Smart Money</author>
      <pubDate>Tue, 04 Jun 2013 08:52:59 GMT</pubDate>
    </item>
    <item>
      <title>AstraZeneca to Incur $140 Million Charge After Fostamatinib Disappointment</title>
      <link>http://www.fool.com/news/xt/smartmoney/www.smartmoney.com/news/on/.aspx?story=on-20130604-000061&amp;cid=1244&amp;source=itxwebtxt0000015</link>
      <author>Smart Money</author>
      <pubDate>Tue, 04 Jun 2013 02:31:00 GMT</pubDate>
    </item>
    <item>
      <title>April's Unhealthiest Stocks</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/04/aprils-unhealthiest-stocks/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Sat, 04 May 2013 08:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Rigel Pharmaceuticals Becomes Oversold (RIGL)</title>
      <link>http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11913893/1/rigel-pharmaceuticals-becomes-oversold-rigl.html.aspx?puc=aol&amp;cm_ven=aol&amp;source=itxwebtxt0000015</link>
      <author>TheStreet</author>
      <pubDate>Fri, 03 May 2013 16:25:00 GMT</pubDate>
    </item>
    <item>
      <title>3 Biggest Biotech Crashes in April</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/01/3-biggest-biotech-crashes-in-april/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Wed, 01 May 2013 20:18:00 GMT</pubDate>
    </item>
    <item>
      <title>5 Health Care Stocks Under $10 Ready to Rip Higher</title>
      <link>http://www.fool.com/news/xt/thestreet/www.stockpickr.com/5-health-care-stocks-under-10-ready-rip-higher.html.aspx?puc=aol&amp;cm_ven=aol&amp;source=itxwebtxt0000015</link>
      <author>TheStreet</author>
      <pubDate>Thu, 18 Apr 2013 21:22:00 GMT</pubDate>
    </item>
    <item>
      <title>5 Stocks Poised for Breakouts</title>
      <link>http://www.fool.com/news/xt/thestreet/www.stockpickr.com/5-stocks-poised-breakouts.html-29.aspx?puc=aol&amp;cm_ven=aol&amp;source=itxwebtxt0000015</link>
      <author>TheStreet</author>
      <pubDate>Fri, 12 Apr 2013 13:32:00 GMT</pubDate>
    </item>
    <item>
      <title>AZN Reports Data on Fostamatinib - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/96563/azn-reports-data-on-fostamatinib.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Mon, 08 Apr 2013 18:35:01 GMT</pubDate>
    </item>
    <item>
      <title>Small Pharma Watch List: Week Of April 8, 2013</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1327141-small-pharma-watch-list-week-of-april-8-2013.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Mon, 08 Apr 2013 11:03:41 GMT</pubDate>
    </item>
  </channel>
</rss>
